Acurx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has compl…

Biotechnology
US, Staten Island [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Acurx Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Acurx Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Acurx Pharmaceuticals, Inc..

End of ACXP's Analysis
CIK: 1736243 CUSIP: 00510M104 ISIN: US00510M1045 LEI: - UEI: -
Secondary Listings
ACXP has no secondary listings inside our databases.